- Technology Available for Industry-Academia Collaboration or Technology Licensing. “Opioid Receptor Allosteric Modifier: DBPR116” (2021/1/28)
- NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17
- Technology Available for Technology Licensing. “Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine(Jul 20,2020)
- Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
- Technology Available for Industry-Academia Collaboration or Technology Licensing. “A Potential COVID-19 Therapeutic Compound”(2020/4/16)
Patents
- 2021(until 2021/02/08)
| Issue date | Patent Title | Patent No. |
|---|---|---|
| 2020/1/1 | BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER’S DISEASE OR HUNTINGTON’S DISEASE | TWI715156 |